Regeneron Pharmaceuticals, Inc.Equity-NMS: REGN
Equity-NMS: REGN
$946.87
-1.14
(20 Feb)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$946.87
Open
$946.87
Today’s high
$963.00
Today’s low
$943.73
52W low
$684.81
52W high
$973.99
1Y
26.22%
5Y
17.50%
PE
25.88
EPS (TTM)
34.77
Shares O/S
107.94M
Market cap
102.21B
Insights
REGN has made a new 52 Wk high. 52 Wk high stocks tend to outperform in the near term.
REGN price is above its 200 day moving average
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. The Company invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic conditions, infectious diseases, and rare diseases.

It helps in accelerating and improving the traditional drug development process through its VelociSuite technologies, such as VelocImmune, which uses genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center. Its marketed products include EYLEA (aflibercept) Injection; Dupixent (dupilumab) Injection; Libtayo (cemiplimab) Injection; Praluent (alirocumab) Injection; REGEN-COV; Kevzara (sarilumab) Injection, and others. .


FAQs

Can I buy Regeneron Pharmaceuticals, Inc. shares in India?
How to buy Regeneron Pharmaceuticals, Inc. shares in India?
What is the share price of Regeneron Pharmaceuticals, Inc.?
What is the Market Capitalization of Regeneron Pharmaceuticals, Inc.?
What is the PE ratio of Regeneron Pharmaceuticals, Inc.?
Is Regeneron Pharmaceuticals, Inc. a good stock to buy?
In which sector / industry does Regeneron Pharmaceuticals, Inc. operate?